Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(2):220–224. doi: 10.1054/bjoc.2001.1870

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue

L-Y Luo 1,2, E Rajpert-De Meyts 3, K Jung 4, E P Diamandis 1,2
PMCID: PMC2364047  PMID: 11461080

Abstract

The normal epithelial cell-specific 1 (NES1) gene (official name kallikrein gene 10; KLK10) is a new member of the expanding human kallikrein gene family and encodes for a secreted serine protease. Experimental evidence suggests that NES1 controls normal cell growth and may function as a tumour suppressor. NES1 is down-regulated during breast cancer progression. The NES1 gene is highly expressed in testicular as well as in other tissues. In this study, we investigated the expression level of the NES1 gene in cancerous and normal testicular tissues with reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry. In all 14 primary testicular germ-cell tumours examined, the NES1 gene expression was markedly reduced compared to adjacent (paired) normal tissues. We further examined 6 randomly selected primary germ-cell tumours and 8 normal tissues (obtained from different individuals). We confirmed the differential expression of the NES1 gene in germ-cell tumours (GCT) and pre-malignant carcinoma in situ (CIS). Our findings suggest that NES1 may act as a tumour suppressor and may play a role in the pathogenesis and progression of this malignancy. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: normal epithelial cell-specific 1 (NES1) gene, KLK10, kallikrein, testicular cancer, down-regulation, tumour suppressor genes

Full Text

The Full Text of this article is available as a PDF (157.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. W. Teratocarcinomas and human embryology: pluripotent human EC cell lines. Review article. APMIS. 1998 Jan;106(1):158–168. doi: 10.1111/j.1699-0463.1998.tb01331.x. [DOI] [PubMed] [Google Scholar]
  2. Bartkova J., Thullberg M., Rajpert-De Meyts E., Skakkebaek N. E., Bartek J. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours. Int J Cancer. 2000 Feb 1;85(3):370–375. doi: 10.1002/(sici)1097-0215(20000201)85:3<370::aid-ijc13>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  3. Dean R. C., Moul J. W. New tumor markers of testis cancer. Urol Clin North Am. 1998 Aug;25(3):365–373. doi: 10.1016/s0094-0143(05)70027-6. [DOI] [PubMed] [Google Scholar]
  4. Diamandis E. P., Yousef G. M., Luo L. Y., Magklara A., Obiezu C. V. The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol Metab. 2000 Mar;11(2):54–60. doi: 10.1016/s1043-2760(99)00225-8. [DOI] [PubMed] [Google Scholar]
  5. Einhorn L. H. Salvage therapy for germ cell tumors. Semin Oncol. 1994 Aug;21(4 Suppl 7):47–51. [PubMed] [Google Scholar]
  6. Goyal J., Smith K. M., Cowan J. M., Wazer D. E., Lee S. W., Band V. The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 1998 Nov 1;58(21):4782–4786. [PubMed] [Google Scholar]
  7. Heidenreich A., Gaddipati J. P., Moul J. W., Srivastava S. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. J Urol. 1998 May;159(5):1725–1730. doi: 10.1097/00005392-199805000-00101. [DOI] [PubMed] [Google Scholar]
  8. Lee S. W., Tomasetto C., Sager R. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2825–2829. doi: 10.1073/pnas.88.7.2825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Liu X. L., Wazer D. E., Watanabe K., Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 1996 Jul 15;56(14):3371–3379. [PubMed] [Google Scholar]
  10. Looijenga L. H., Oosterhuis J. W. Pathogenesis of testicular germ cell tumours. Rev Reprod. 1999 May;4(2):90–100. doi: 10.1530/ror.0.0040090. [DOI] [PubMed] [Google Scholar]
  11. Luo L., Herbrick J. A., Scherer S. W., Beatty B., Squire J., Diamandis E. P. Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem Biophys Res Commun. 1998 Jun 29;247(3):580–586. doi: 10.1006/bbrc.1998.8793. [DOI] [PubMed] [Google Scholar]
  12. Magklara A., Scorilas A., Catalona W. J., Diamandis E. P. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. Clin Chem. 1999 Nov;45(11):1960–1966. [PubMed] [Google Scholar]
  13. Oesterling J. E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991 May;145(5):907–923. doi: 10.1016/s0022-5347(17)38491-4. [DOI] [PubMed] [Google Scholar]
  14. Rajpert-De Meyts E., Jørgensen N., Brøndum-Nielsen K., Müller J., Skakkebaek N. E. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS. 1998 Jan;106(1):198–206. doi: 10.1111/j.1699-0463.1998.tb01336.x. [DOI] [PubMed] [Google Scholar]
  15. Skakkebaek N. E., Berthelsen J. G., Giwercman A., Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 1987 Feb;10(1):19–28. doi: 10.1111/j.1365-2605.1987.tb00161.x. [DOI] [PubMed] [Google Scholar]
  16. Skakkebaek N. E. Possible carcinoma-in-situ of the testis. Lancet. 1972 Sep 9;2(7776):516–517. doi: 10.1016/s0140-6736(72)91909-5. [DOI] [PubMed] [Google Scholar]
  17. Stamey T. A., Yang N., Hay A. R., McNeal J. E., Freiha F. S., Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987 Oct 8;317(15):909–916. doi: 10.1056/NEJM198710083171501. [DOI] [PubMed] [Google Scholar]
  18. Strohmeyer T., Reissmann P., Cordon-Cardo C., Hartmann M., Ackermann R., Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6662–6666. doi: 10.1073/pnas.88.15.6662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Yu H., Giai M., Diamandis E. P., Katsaros D., Sutherland D. J., Levesque M. A., Roagna R., Ponzone R., Sismondi P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res. 1995 May 15;55(10):2104–2110. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES